“There has been no better time to invest in Israel”

Juan Delgado credit: Courtesy Hamilton Lane
Juan Delgado credit: Courtesy Hamilton Lane

Alternative investments manager Hamilton Lane co-CEO Juan Delgado says Israel’s lower valuation environment provides ideal investment opportunities.

It’s impossible to miss the Spanish accent when talking to Juan Delgado, who currently manages huge investments in the alternative market. Born and raised in Spain he had wanted to become a professional soccer player, "That was my dream. I was quite good when I was 17 but then you realize your limits."

After a brief career in academia he moved into the field of private investments in which he has now been specializing for 25 years. The world of investments is familiar to him, as his father worked in banking. "I was exposed to banks since I was a child and I helped my father manage accounts from a young age," he recalls. "It was something we did at home, but investing is more than money, it's research, analysis and data management to gain insights into risk-taking. It's a specialization and an intellectual journey. Inside I'm a statistician," he says, and that's how he thinks about investment.

Aged 54, he lives in Hong Kong and serves as co-CEO of Hamilton Lane and is a member of the investment committee of the company that was founded 33 years ago and currently manages assets worth $124 billion. Hamilton Lane also advises companies, qualified investors (those with large liquid capital) and various entities that manage funds worth a combined $810 billion, and it is one of the largest firms in the world in its field. The company is traded on Nasdaq at a market cap of $10 billion and revenue last year was $452 million with a net profit of $141 million.

"We are in Israel to stay in Israel"

The enthusiasm in his voice regarding Israel is difficult to miss. Since the outbreak of the war, he has visited Israel five times, and he explains that he is not the only one from the company to come here in the midst of the fighting. Hamilton Lane has invested more than a billion dollars in Israel, in various private companies, a large part of it in recent years, including since the outbreak of the war. The company also has a representative office in Israel with 10 employees and a managing director - Limor Beker.

For him, this is just the beginning: "Hamilton Lane intends to continue investing in Israel in the years to come. We are here to stay.

"I was born in the Basque country, which I think helps with understanding smaller countries like Israel," he says with a smile and adds that his investment is purely rational and economic. He adds, "While Israel is a small country, it’s the leading high-tech market in the world. You’re not the best footballing nation, for example, but you are the leading high-tech market, and that’s something to take pride in. It’s already proven with defense technology and other sectors."

Aren't you afraid to invest in Israel at a time like this?

"On the contrary, I believe now is the best time to invest in Israel. We’ve been active in Israel for over 20 years, in high-tech, private markets, and various funds. Even after the October 7th attack, we’ve closed deals and are among the most active investors in Israel. Why invest now? There’s a lower valuation environment globally, especially in venture capital and growth assets, and many people are hesitant, which reduces competition. This combination of quality assets and good entry prices makes it an ideal time. There are many investment opportunities at reasonable prices, in companies that manage to survive in a challenging environment. Therefore, we are generally increasing our activity in Israel."

He also refuses to be deterred by the rating agencies' downgrades of Israel's credit rating. "These ratings affect the cost of the country's loans. But I invest in the private markets. This is a much longer-term investment. The effect of downgrading is not immediate, and I also believe that it is temporary," he says.

Prepare for volatility in the stock market

When interest rates are high and stock market prices are at their peak, many recommend taking advantage of the relatively high yields in the bond market. But Delgado is a big believer in private investment, and to the question of whether today is not an appropriate time to invest specifically in bonds in the tradable market that give a yield of 4-5% per year, he answers with a question: "Are you happy with 4%? Probably not, especially since you’re investing for the long term. Young investors with extended timelines shouldn’t settle for low-risk, low-return assets. They should look to achieve higher returns, and private markets are ideal for this."

However, the majority of the public does not have direct access to the private market, other than through their savings in investments made in the pension and provident fund institutions.

The strength of Delgado's belief in the private market can also be seen through the large share he allocates to investment in the sector in the investment portfolio he recommends, half in the public market and half in the private sector. Out of the entire portfolio, he allocates 30% to shares abroad, 20% to bonds abroad, 30% to private equity (shares of private companies) and another 20% to private debt. The small investor cannot invest in these areas directly, but can be exposed to them through the general channels in the provident funds and pension funds.

He justifies the allocation of the shortfall to the stock market by saying, "The US economy has proven to be stronger than most models predicted and remains the best global allocation. We don’t believe it’s time to rebalance out of the US. In fact, we expect an upside surprise in consumer strength, innovation, and GDP growth. Equity valuations in public markets are very high, which suggests they’ll trend downwards, with increased volatility driven by political events, elections, global macro factors, and the Fed's changing rate expectations. We anticipate only a 25 basis point rate adjustment, with possible pauses through 2025, leading to near-term equity volatility and potential opportunities to buy during significant corrections."

Opportunities in infrastructure shares

When he looks at his preferred sectors, Delgado sees "many opportunities in the field of infrastructure, in the US, Europe and also in Israel, but not in Asia - starting with logistics, through renewable energies and digitization such as data centers." He adds, "There is enormous potential here for investment, in new construction, in upgrading facilities and in a variety of subfields in this industry. We see a renewed revival in the field of production. The world needed more production, and the lack of production is reflected in the stock price of companies like Nvidia, which reminds one of the times when companies like Cisco and Intel dominated the market. The concentration of cheap production in the world today brings with it risks, and we estimate that during the next decade we will see a correction of this phenomenon."

Published by Globes, Israel business news - en.globes.co.il - on November 5, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Juan Delgado credit: Courtesy Hamilton Lane
Juan Delgado credit: Courtesy Hamilton Lane
Dr. Neal Tsur credit: Yossi Zamir "Trump was just an excuse for market drop"

Dr. Neal Tsur studies what makes complex systems like stock markets ripe for change, and he has put his money where his theory is.

Roy Goldenberg  credit: Jonathan Bloom Making a better world for the disabled

Personal experience motivated Roy Goldenberg to become Israel director of TOM Tikkun Olam Makers. "TOM will be one of the biggest organizations to come out of Israel," he says.

Itay Raved  credit: Jonathan Bloom From a rooftop in India to running Tesla Israel

Itay Raved's career drifted from law to media consulting to acting, before he finally found his niche.

Dr. Adi Tzoref-Lorenz credit: Jonathan Bloom "My research says I don't accept there is no answer"

The death of a cancer patient spurred Dr. Adi Zoref-Lorenz into developing the OHI index, which allows the diagnosis of the HLH side effect from cancer immunotherapy, based on two blood tests.

Dr. R  credit: Jonathan Bloom Wounded in his tank, now R develops protection systems

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Record public company profits  credit: Tali Bogdanovsky Profits peak, but reckoning awaits

In what may seem a paradox, profits grew in almost every sector on the Tel Aviv Stock Exchange last year, but the boom was largely fueled by government spending.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Amit Shaked credit: Tomer Lesher Driven to succeed but balancing ambition with wellbeing

At just 14, cybersecurity company Rubrik VP Amit Shaked began a B.Sc. in Computer Science and Math and mapped out his entire future, which included IDF service in the 8200 unit, and an inevitable huge startup exit.

Advs. Roy Keidar and Netanella Treistman credit: Nicky Westphal AI blind spot startups can no longer afford to ignore

How AI governance can assist startups and enhance their ability to succeed.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Google CEO Sundar Pichai  crediit: Shutterstock Why Google is paying so much for Wiz

Lagging its competitors in cloud and AI, and facing challenges to its core advertising business, Google could be looking to spend its way out of trouble.

Donald Trump speaking on the deck of the USS Gerald R. Ford  at its launch in 2017 credit: Reuters/Jonathan Ernst Houthis between hammer and anvil

President Trump appears determined to end the Houthi threat to shipping, while Iran has abandoned the last active arm of its "axis of resistance."

Prof. Douglas Irwin  credit: Inbal Marmari "We will all be poorer"

Prof. Douglas Irwin, an expert on international trade, talks to "Globes" about the impact of President Trump's tariffs policy, and what Israel can do about it.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018